ARCHIVES

Docetaxel, Oxaliplatin Active Against Esophageal Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 6 | June 30, 2006

Download PDF Visit The Full Archive

Related Articles

In Brief: ACS to Spend Record $85 Million On Research: AACR To Honor Hanafusa, DeVita, Barbacid

March 14, 1986

Feinstein Reintroduces New National Cancer Act

June 13, 2003

In Brief: NCI Rushing To Complete Development Of Program Grants System By June 30

May 17, 1974

NCAB Subcommittee Suggests Comp Centers Must Have Core Grants

September 22, 1978

Colorectal Cancer Screening Programs Could Cut Future Treatment Costs

September 25, 2009

NCI Funds New Centers At Stanford, Baylor.

June 15, 2007